Skip to main content
. 2019 Dec 3;12:1756286419892360. doi: 10.1177/1756286419892360

Table 4.

EDSS trends subsequent To ITMTX therapy.

MS type Stable/improved EDSS Declined EDSS
PPMS 6 (37.5%) 10 (62.5%)
SPMS 36 (54%) 31 (46%)
Total 42 (50%) 41 (50%)

Values reported as n (%).

EDSS, Kurtze expanded disability status scale; ITMTX, intrathecal methotrexate; PPMS, primary progressive multiple sclerosis; SPMS secondary progressive multiple sclerosis.